Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monthly Vaginal Suppositories for Preventing Vaginal Infections
NCT01230814Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Apr 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in bacterial vaginosis (BV), vulvovaginal candidiasis (VVC) and trichomoniasis (trich) comparing Metronidazole + Miconazole with Placebo (2 arms). Primary endpoints: Efficacy of Monthly Periodic Presumptive Treatment for Preventing Vulvovaginal Candidiasis at 12 months and Efficacy of Monthly Periodic Presumptive Treatment for Preventing Bacterial Vaginosis at 12 months. Started Apr 2011; status: completed.
02
Drugs
metronidazolemiconazole
03
Conditions
bacterial vaginosis (BV)vulvovaginal candidiasis (VVC)trichomoniasis (trich)
Beyond the preview
Go deeper on NCT01230814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01230814.